Dr Reddy's Laboratories likely to launch Sputnik V under EUA in March

The bridge trials on 1,600 participants in India was ongoing. The phase 2 trials are completed and the phase 3 is on.

Coronavirus, vaccine, covid, drugs, clinical trials

On the pricing front, the firm said it was discussing the Indian situation with RDIF.

Dr Reddy’s Laboratories (DRL) plans to apply for emergency use approval (EUA) for the Russian Sputnik V from the Indian drug regulator in March and launch the vaccine around the

Also Read

Russian vaccine on its way to India, pact signed with Dr Reddy's for trials

Covid-19: Dr Reddy's to distribute Russian vaccine in India. What we know

Russia asked to apply for Sputnik V vaccine trials in India via local rep

Dr Reddy's yet to apply for clinical trials of Sputnik V Covid-19 vaccine

Dr Reddy's gets nod for 2/3 vaccine trial; Key updates about the virus

Novavax Covid-19 vaccine shows 89% efficacy in UK clinical trials

Localisation strategy for jobs would help address protectionism: Nilekani

Tata Motors expects to complete PV biz hive-off by June this year

Dr Reddy s eyes to launch Sputnik V vaccine for Covid-19 under EUA in March

Reliance races past TCS to become most-valued domestic firm once again

First Published: Jan 30 2021 | 0:42 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to